Association of lncRNA PRNCR1 Polymorphisms and Cancer Susceptibility in Asian Populations: A Meta-an

来源 :肿瘤营养学杂志(英文) | 被引量 : 0次 | 上传用户:qingjietianjiao
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Prostate cancer non-coding RNA 1 (PRNCR1),a lncRNA transcribed from 8q24,is involved in carcinogenesis and development of varies cancer.Several molecular epidemiology studies revealed that the association between PRNCR1 single-nucleotide polymorphisms (SNPs) and cancer risk,but the results remain controversial.In order to derive a more precise evaluation,we conducted a meta-analysis to summarize all eligible case-control studies to evaluate the association between SNPs in PRNCR1 and the overall cancer susceptibility.A systematic literature search on PubMed and Web of science database was up to January 1st,2017.Finally,a total of six articles involving 2804 cases and 3233 controls samples were included in this meta-analysis.Homozygous,heterozygous,dominant,recessive and allelic models were used to analyze the associations between SNPs in PRNCR1 and cancer risk in the Asian population by using the odds ratio (OR) and 95% confidence interval (95%CIs).Heterogeneity and publication bias were used to measure the robustness of our findings.Significant associations between the PRNCR1 rs16901946 polymorphism and cancer risk were observed (GG vs.AA+AG:OR =1.19,95% CI =1.07-1.32,P =0.002,I2=0.0%) in Asian population.Moreover,subgroup analyses by cancer type indicated that rs1016343 C > T and rs16901946 A >G was associated with an increase prostate cancer risk.In addition,no significant association was detected between rs13252298 A > G and rs7007694 C > T polymorphism and cancer susceptibility.In conclusion,our meta-analysis suggests that PRNCR1 polymorphisms may be associated with cancer susceptibility in Asian populations,particularly in prostate cancer.
其他文献
达纳康(TNK)是标准化的银杏叶萃取物(EGb761),其主要有效成分是黄酮糖苷和萜内酯,它对于改善脑缺血具有多方面的药理作用.我们于1997年7月~1998年7月应用达纳康治疗急性脑梗死
目的:分析他汀类药物在早期糖尿病肾病治疗中的应用研究.方法:选取我院2017年1月到2018年1月74例患者,随机均分为两组,每组各37例患者,对照组给予常规治疗,试验组在常规治疗
【摘 要】目的:探讨整体护理对消化溃疡治疗应激反应的影响。方法:消化性溃疡病人160例根据挂号单双号的不同分为治疗组与对照组各80例,对照组常规给予中西药结合治疗与常规护理,在此基础上治疗组给予积极的整体护理干预。结果:对照组总有效率为87.5%,治疗组的总有效率为96.3%,组间对比差异明显(P0.05),治疗后评分都有明显下降,同时组间对比差异明显(P0.05)。  1.2 治疗方法  对照组
期刊
运用我院药剂科研制的结肠康颗粒治疗慢性结肠炎104例,获得满意效果,现报告如下.
目的:总结奥美拉唑联合雷尼替丁治疗消化性溃疡幽门螺杆菌(HP)感染的疗效.方法:在2018年1月到2018年12月选取我院接受诊治的30例消化性溃疡HP感染患者作为案例进行研究分析.
(一 )田慧中教授 192 8年 2月出生于山东省禹城县 ,195 0年毕业于河南大学医学院 ,195 7年起专攻骨科。在骨科的临床实践中 ,面对着许许多多因脊柱疾病导致脊柱畸形而饱受身
期刊
【摘 要】目的:探讨和分析冠状动脉内支架置入手术后抗凝治疗和护理的临床效果。方法:将我院此次收治的85例冠状动脉内支架置入手术患者,术后将这些患者按照随机数字表法分组为试验组(43例)和对照组(42例);对照组:术后对患者采用抗凝治疗,同时对患者进行一般的常规护理;试验组:在对照组治疗和护理基础上,对患者实施针对性的护理。结果: 经过治疗和护理后,试验组发生皮下水肿和消化道出血等并发症的患者为4例
期刊
目的通过基因靶向技术将纳米粒与p53及Rb两种抗癌基因联合,探索其对兔VX2肿瘤肝转移癌灶的治疗效果并评价其生物安全性。方法以超液化碘油及多聚赖氨酸(PLL)修饰的羟基磷灰石纳米颗粒(nHAP)乳剂为载体,将含有野生型p53、Rb基因的重组表达质粒经肝动脉共同或者分别转运至兔VX2肿瘤肝转移灶局部,采用蛋白印迹法及原位共聚焦激光显微镜确定p53及Rb共表达蛋白的表达。通过肝功能检测评价此疗法的生物
目的:探讨超声检查在高龄产妇胎儿肢体畸形中的诊断效果及临床价值.方法:选取2016年1月-2018年1月我院收治的156例高龄产妇,对高龄产妇进行超声检查,并与出生和引产随访结果